Item 1. Financial Statements.
PEGASUS DIGITAL MOBILITY ACQUISITION CORP.
CONDENSED BALANCE SHEETS
​
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | September 30, | December 31, |
| ​ | 2022 | 2021 |
| ASSETS | ​ | (unaudited) | ​ | ​ |
| Current assets | ​ | ​ | ​ | ​ | ​ | ​ |
| Cash | ​ | $ | 501,294 | ​ | $ | 1,031,397 |
| Prepaid expenses – current | ​ | 249,014 | ​ | 722,726 |
| Total Current Assets | ​ | ​ | 750,308 | ​ | ​ | 1,754,123 |
| Non-current assets | ​ | ​ | ​ | ​ | ​ | ​ |
| Marketable securities held in Trust Account | ​ | ​ | 228,489,526 | ​ | ​ | 227,262,051 |
| Prepaid expenses – non-current | ​ | ​ | — | ​ | ​ | 50,701 |
| Total Non-current Assets | ​ | ​ | 228,489,526 | ​ | ​ | 227,312,752 |
| Total Assets | ​ | $ | 229,239,834 | ​ | $ | 229,066,875 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ​ | ​ | ​ |
| Current liabilities | ​ | ​ | ​ | ​ | ​ | ​ |
| Accounts payable | ​ | $ | 202,151 | ​ | $ | 2,119 |
| Accrued expenses | ​ | ​ | 6,594 | ​ | ​ | 193,300 |
| Due to related party | ​ | ​ | 158,139 | ​ | ​ | 42,776 |
| Total Current Liabilities | ​ | ​ | 366,884 | ​ | ​ | 238,195 |
| Non-current liabilities | ​ | ​ | ​ | ​ | ​ | ​ |
| Warrant liabilities | ​ | ​ | 4,205,250 | ​ | ​ | 11,048,250 |
| Deferred underwriting commissions | ​ | ​ | 7,875,000 | ​ | ​ | 7,875,000 |
| Total Non-current Liabilities | ​ | 12,080,250 | ​ | 18,923,250 |
| Total Liabilities | ​ | 12,447,134 | ​ | ​ | 19,161,445 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Commitments and Contingencies (Note 7) | ​ | ​ | ​ |
| Class A ordinary shares subject to possible redemption, 22,500,000 shares issued and outstanding at redemption value | ​ | ​ | 228,489,526 | ​ | ​ | 227,262,051 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Shareholders’ Deficit | ​ | ​ | ​ |
| Preference shares, $ 0.0001 par value; 2,000,000 shares authorized; none issued and outstanding | ​ | ​ | — | ​ | ​ | — |
| Class A ordinary shares, $ 0.0001 par value, 200,000,000 shares authorized; 0 shares issued and outstanding (excluding 22,500,000 shares subject to possible redemption) | ​ | — | ​ | — |
| Class B ordinary shares, $ 0.0001 par value, 20,000,000 shares authorized; 5,625,000 shares issued and outstanding | ​ | 563 | ​ | 563 |
| Additional paid-in capital | ​ | — | ​ | — |
| Accumulated deficit | ​ | ( 11,697,389 ) | ​ | ( 17,357,184 ) |
| Total Shareholders’ Deficit | ​ | ( 11,696,826 ) | ​ | ( 17,356,621 ) |
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ​ | $ | 229,239,834 | ​ | $ | 229,066,875 |

​
The accompanying notes are an integral part of these unaudited condensed financial statements.
​
3
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | For the Period |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | from March 30, |
| ​ | ​ | For the Three | ​ | For the Three | ​ | For the Nine | ​ | 2021 (inception) |
| ​ | ​ | Months Ended | ​ | Months Ended | ​ | Months Ended | ​ | Through |
| ​ | September 30, 2022 | September 30, 2021 | September 30, 2022 | September 30, 2021 |
| Listing fee amortization expense | ​ | $ | 21,250 | ​ | $ | — | ​ | $ | 63,750 | ​ | $ | — |
| Administrative expenses | ​ | ​ | 51,847 | ​ | ​ | — | ​ | ​ | 200,127 | ​ | ​ | — |
| Legal and accounting expenses | ​ | ​ | 72,197 | ​ | ​ | — | ​ | ​ | 384,628 | ​ | ​ | — |
| Insurance expense | ​ | ​ | 178,233 | ​ | ​ | — | ​ | ​ | 534,700 | ​ | ​ | — |
| Formation costs | ​ | ​ | — | ​ | ​ | 7,193 | ​ | ​ | — | ​ | ​ | 17,001 |
| Operating expenses | ​ | ​ | 323,527 | ​ | ​ | 7,193 | ​ | ​ | 1,183,205 | ​ | ​ | 17,001 |
| Loss from operations | ​ | ​ | ( 323,527 ) | ​ | ​ | ( 7,193 ) | ​ | ​ | ( 1,183,205 ) | ​ | ​ | ( 17,001 ) |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Other income: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Unrealized gain on fair value changes of warrants | ​ | ​ | 4,205,250 | ​ | ​ | — | ​ | ​ | 6,843,000 | ​ | ​ | — |
| Interest earned on marketable securities held in Trust Account | ​ | ​ | 381,037 | ​ | ​ | — | ​ | ​ | 461,238 | ​ | ​ | — |
| Unrealized gain on marketable securities, dividends and interest on cash held in Trust Account | ​ | ​ | 566,602 | ​ | ​ | — | ​ | ​ | 766,237 | ​ | ​ | — |
| Other income | ​ | ​ | 5,152,889 | ​ | ​ | — | ​ | ​ | 8,070,475 | ​ | ​ | — |
| Net income (loss) | ​ | $ | 4,829,362 | ​ | $ | ( 7,193 ) | ​ | $ | 6,887,270 | ​ | $ | ( 17,001 ) |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Weighted average shares outstanding, Class A ordinary shares subject to possible redemption | ​ | ​ | 22,500,000 | ​ | ​ | — | ​ | ​ | 22,500,000 | ​ | ​ | — |
| Basic and diluted net income per share, Class A ordinary shares subject to possible redemption | ​ | $ | 0.18 | ​ | $ | — | ​ | $ | 0.26 | ​ | $ | — |
| Weighted average shares outstanding, Class B ordinary shares | ​ | ​ | 5,625,000 | ​ | ​ | 5,625,000 | ​ | ​ | 5,625,000 | ​ | ​ | 5,625,000 |
| Basic and diluted net income (loss) per share, Class B ordinary shares | ​ | $ | 0.14 | ​ | $ | ( 0.00 ) | ​ | $ | 0.20 | ​ | $ | ( 0.00 ) |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Class A | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Ordinary Shares Subject to Possible | ​ | ​ | Class B | ​ | Additional | ​ | ​ | ​ | Total |
| ​ | ​ | Redemption | ​ | ​ | Ordinary shares | ​ | Paid-in | ​ | Accumulated | ​ | Shareholders’ |
| ​ | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit |
| Balance - December 31, 2021 | ​ | 22,500,000 | ​ | $ | 227,262,051 | ​ | ​ | 5,625,000 | ​ | $ | 563 | ​ | $ | — | ​ | $ | ( 17,357,184 ) | ​ | $ | ( 17,356,621 ) |
| Accretion of Class A ordinary shares to redemption value | — | ​ | ​ | 41,520 | ​ | ​ | — | ​ | — | ​ | — | ​ | ( 41,520 ) | ​ | ( 41,520 ) |
| Net income | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 576,936 | ​ | ​ | 576,936 |
| Balance - March 31, 2022 | ​ | 22,500,000 | ​ | ​ | 227,303,571 | ​ | ​ | 5,625,000 | ​ | ​ | 563 | ​ | ​ | — | ​ | ​ | ( 16,821,768 ) | ​ | ​ | ( 16,821,205 ) |
| Accretion of Class A ordinary shares to redemption value | ​ | — | ​ | ​ | 238,316 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 238,316 ) | ​ | ​ | ( 238,316 ) |
| Net income | — | ​ | ​ | — | ​ | ​ | — | ​ | — | ​ | — | ​ | 1,480,972 | ​ | 1,480,972 |
| Balance - June 30, 2022 | 22,500,000 | ​ | ​ | 227,541,887 | ​ | ​ | 5,625,000 | ​ | ​ | 563 | ​ | ​ | — | ​ | ​ | ( 15,579,112 ) | ​ | ​ | ( 15,578,549 ) |
| Accretion of Class A ordinary shares to redemption value | ​ | — | ​ | ​ | 947,639 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 947,639 ) | ​ | ​ | ( 947,639 ) |
| Net income | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 4,829,362 | ​ | ​ | 4,829,362 |
| Balance - September 30, 2022 | ​ | 22,500,000 | ​ | $ | 228,489,526 | ​ | ​ | 5,625,000 | ​ | $ | 563 | ​ | $ | — | ​ | $ | ( 11,697,389 ) | ​ | $ | ( 11,696,826 ) |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Class A | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Ordinary Shares Subject to Possible | ​ | ​ | Class B | ​ | Additional | ​ | ​ | ​ | Total |
| ​ | ​ | Redemption | ​ | ​ | Ordinary shares | ​ | Paid-in | ​ | Accumulated | ​ | Shareholders’ |
| ​ | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit |
| Balance - March 30, 2021 (inception) | ​ | — | ​ | $ | — | ​ | ​ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — |
| Net income | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — |
| Balance - March 31, 2021 | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — |
| Class B ordinary shares issued to Sponsor | ​ | — | ​ | ​ | — | ​ | ​ | 5,750,000 | ​ | ​ | 575 | ​ | ​ | 24,425 | ​ | ​ | — | ​ | ​ | 25,000 |
| Net loss | — | ​ | ​ | — | ​ | ​ | — | ​ | — | ​ | — | ​ | ( 9,808 ) | ​ | ( 9,808 ) |
| Balance - June 30, 2021 | — | ​ | ​ | — | ​ | ​ | 5,750,000 | ​ | ​ | 575 | ​ | ​ | 24,425 | ​ | ​ | ( 9,808 ) | ​ | ​ | 15,192 |
| Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 7,193 ) | ​ | ​ | ( 7,193 ) |
| Balance - September 30, 2021 | ​ | — | ​ | $ | — | ​ | ​ | 5,750,000 | ​ | $ | 575 | ​ | $ | 24,425 | ​ | $ | ( 17,001 ) | ​ | $ | 7,999 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | For the Period |
| ​ | ​ | ​ | ​ | from March 30, |
| ​ | ​ | For the Nine | ​ | 2021 (inception) |
| ​ | ​ | Months Ended | ​ | Through |
| ​ | September 30, 2022 | September 30, 2021 |
| Cash Flows from Operating Activities: | ​ | ​ | ​ | ​ |
| Net income (loss) | ​ | $ | 6,887,270 | ​ | $ | ( 17,001 ) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ​ | ​ | ​ | ​ | ​ | ​ |
| Formation costs paid by the Sponsor for issuance of Class B ordinary shares | ​ | ​ | — | ​ | ​ | 6,808 |
| Interest earned on marketable securities held in Trust Account | ​ | ​ | ( 461,238 ) | ​ | ​ | — |
| Unrealized gain on marketable securities, dividends and interest on cash held in Trust Account | ​ | ​ | ( 766,237 ) | ​ | ​ | — |
| Unrealized gain on fair value changes of warrants | ​ | ​ | ( 6,843,000 ) | ​ | ​ | — |
| Changes in operating assets and liabilities: | ​ | ​ | ​ | ​ | ​ | ​ |
| Prepaid expenses | ​ | ​ | 524,413 | ​ | ​ | — |
| Accounts payable | ​ | ​ | 200,032 | ​ | ​ | — |
| Accrued expenses | ​ | ​ | ( 186,706 ) | ​ | ​ | 10,193 |
| Due to related party | ​ | ​ | 115,363 | ​ | ​ | — |
| Net cash used in operating activities | ​ | ​ | ( 530,103 ) | ​ | ​ | — |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Cash flow from investing activities: | ​ | ​ | ​ | ​ | ​ | ​ |
| Proceeds from redemption of securities held in Trust Account | ​ | ​ | 344,244,000 | ​ | ​ | — |
| Purchase of securities held in Trust Account | ​ | ​ | ( 344,705,238 ) | ​ | ​ | — |
| Dividends received from interest earned on marketable securities held in Trust Account | ​ | ​ | 461,238 | ​ | ​ | — |
| Net cash used in investing activities | ​ | ​ | — | ​ | ​ | — |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Net Change in Cash | ​ | ​ | ( 530,103 ) | ​ | ​ | — |
| Cash - Beginning | ​ | ​ | 1,031,397 | ​ | ​ | — |
| Cash - Ending | ​ | $ | 501,294 | ​ | $ | — |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Non-Cash Investing and Financing Activities: | ​ | ​ | ​ | ​ | ​ |
| Accretion of Class A ordinary shares subject to possible redemption | ​ | $ | 1,227,475 | ​ | $ | — |
| Deferred offering costs paid by the Sponsor in exchange for issuance of Class B ordinary shares | ​ | $ | — | ​ | $ | 18,192 |
| Deferred offering costs included in accrued offering costs | ​ | $ | — | ​ | $ | 371,191 |
| Deferred offering costs paid in advance | ​ | $ | — | ​ | $ | 2,242 |
| Deferred offering costs paid by Sponsor under the promissory note | ​ | $ | — | ​ | $ | 153,860 |

PEGASUS DIGITAL MOBILITY ACQUISITION CORP. NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS Note 1 - Organization and Business OperationsOrganization and GeneralPegasus Digital Mobility Acquisition Corp. (the “Company”) is a blank check company incorporated in the Cayman Islands on March 30, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or assets (the “Business Combination”). The Company has not selected any Business Combination target.As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation and the initial public offering (the “IPO”), and, since the completion of the IPO, a search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.The Company’s sponsor is Pegasus Digital Mobility Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”).FinancingThe registration statement for the Company’s IPO was declared effective on October 21, 2021. On October 26, 2021, the Company consummated the IPO of 20,000,000 units at $ 10.00 per unit (the “Units”), generating gross proceeds to the Company of $ 200,000,000 . Each Unit consists of one Class A ordinary share, par value $ 0.0001 per share (the “Class A ordinary shares”), and one-half of one redeemable warrant (each whole warrant, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $ 11.50 per whole share, subject to adjustment. The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 3,000,000 Units to cover over-allotments, if any.Simultaneously with the consummation of the IPO, the Company consummated the sale of 9,000,000 warrants (the “Private Placement Warrants”), each exercisable to purchase one Class A ordinary share at $ 11.50 per share, at a price of $ 1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds to the Company of $ 9,000,000 . Depending on the extent to which the underwriters’ over-allotment option was exercised, the Sponsor agreed to purchase an additional 900,000 Private Placement Warrants.On November 4, 2021, the underwriters partially exercised the over-allotment option and, on November 8, 2021, purchased 2,500,000 Units, generating aggregate gross proceeds of $ 25,000,000 . On November 8, 2021, simultaneously with the sale of the over-allotment Units, the Company consummated the private sale of an additional 750,000 Private Placement Warrants, generating gross proceeds to the Company of $ 750,000 .Transaction costs related to the consummation of the IPO on October 26, 2021 amounted to $ 13,124,654 consisting of $ 4,500,000 of underwriting discounts, $ 7,875,000 of deferred underwriting commissions, and $ 749,654 of other offering costs.Prior to the IPO, qualified institutional buyers or institutional accredited investors (the “Anchor Investors”) expressed to the Company an interest in purchasing Units in the IPO in exchange for the Sponsor agreeing to sell the Anchor Investors Class B ordinary shares, par value $ 0.0001 (“Founder Shares”). Upon the closing of the IPO, the Anchor Investors received 1,375,000 Founder Shares (“Anchor Shares”) from the Sponsor. The fair value of the Anchor Shares was treated as an issuance cost of the offering which was allocated to the Class A ordinary shares and Public Warrants.On November 4, 2021, the Sponsor transferred an aggregate of 843,750 Founder Shares to the Company’s officers and independent directors (see Note 6). On December 6, 2021, 125,000 of the Founder Shares were forfeited by the Sponsor as a result of the underwriters’ partial exercise of the over-allotment option and the expiration of the over-allotment option. All shares and per-share amounts have been retroactively restated to reflect the forfeiture of the 125,000 Founder Shares. 7
Trust AccountFollowing the closing of the IPO on October 26, 2021, and the underwriters’ partial exercise of the over-allotment option on November 8, 2021, $ 227,250,000 ($ 10.10 per Unit) from the net proceeds from the sale of the Units in the IPO and a portion of the net proceeds from the sale of the Private Placement Warrants were deposited into a trust account (the “Trust Account”) and is, and will be, invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), that invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds held in the Trust Account will not be released to the Company from the Trust Account until the earliest to occur of: (a) the completion of its initial Business Combination, (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend its amended and restated memorandum and articles of association (i) to modify the substance or timing of its obligation to redeem 100 % of its public shares if the Company does not complete its initial Business Combination within 15 months from the closing of the IPO, which is extendable at the Sponsor’s option up to 21 months as described below (the “Combination Period”) or (ii) with respect to any other provisions relating to shareholders’ rights or pre-initial Business Combination activity; and (c) the redemption of its public shares if the Company is unable to complete its Business Combination within the Combination Period, subject to applicable law.Initial Business CombinationThe initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80 % of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions held in the Trust Account). However, the Company will only complete such Business Combination if the post-transaction company owns or acquires 50 % or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.The Company will have until 15 months from the closing of the IPO, or January 26, 2023 (without extensions), to consummate the initial Business Combination. If the Company anticipates that it may not be able to consummate the initial Business Combination within 15 months, the Company may, by resolution of its board of directors at the option of the Sponsor, extend the period of time the Company will have to consummate an initial Business Combination up to two times, each by an additional three months (for a total of up to an additional six months from the closing of the IPO), subject to the Sponsor contributing $ 0.10 per unit to the Trust Account. The Company’s shareholders will not be entitled to vote on, or redeem their shares in connection with, any such extension. Pursuant to the terms of the amended and restated memorandum and articles of association, in order to extend the period of time to consummate an initial Business Combination in such a manner, the Sponsor must deposit $ 2,250,000 into the Trust Account on or prior to the date of the applicable deadline, for each three-month extension. The Sponsor has the option to accelerate its deposit of one or both halves of the up to $ 4,500,000 at any time following the closing of the IPO and prior to the consummation of the initial Business Combination with the same effect of extending the time the Company will have to consummate an initial Business Combination by three or six months, as applicable. 8
The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (1) in connection with a general meeting called to approve the Business Combination or (2) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will also provide its public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of its initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the completion of its initial Business Combination, including interest (which interest shall be net of taxes payable), divided by the number of then-issued and outstanding Class A ordinary shares that were sold as part of the Units in the IPO, which the Company refers to collectively as its public shares, subject to the limitations described herein. If the Company has not completed its initial Business Combination within the Combination Period, the Company will redeem 100 % of the public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $ 100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then-issued and outstanding public shares, subject to applicable law and as further described herein.The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity,” and subsequently accreted to redemption value.The initial shareholders, directors, officers and advisors have agreed to waive: (i) their redemption rights with respect to any Founder Shares and public shares held by them, as applicable, in connection with the completion of the Company’s initial Business Combination; (ii) their redemption rights with respect to any Founder Shares and public shares held by them in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100 % of the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating the rights of holders of the Class A ordinary shares; and (iii) their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete its initial Business Combination within the Combination Period or during any extended time that the Company has to consummate a Business Combination beyond the Combination Period as a result of a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (an “Extension Period”) (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame) and (iv) vote their Founder Shares and any public shares purchased during or after the IPO in favor of the Company’s initial Business Combination. Each of the Anchor Investors has entered into an investment agreement with the Company pursuant to which they have agreed that any Founder Shares held by them are (i) not entitled to redemption rights in connection with the completion of our initial Business Combination or in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association and (ii) not entitled to liquidating distributions from the Trust Account with respect to any Founder Shares the Anchor Investor holds in the event the Company fails to complete its initial Business Combination within the Combination Period or during any Extension Period.The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $ 10.10 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations. 9
Liquidity and Going ConcernAs of September 30, 2022, the Company had $ 501,294 of cash and working capital of $ 383,424 .The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. Although no formal agreement exists, the Sponsor is committed to extend Working Capital Loans (as defined below) as needed. The Company cannot assure that its plans to consummate an initial Business Combination will be successful. In addition, management is currently evaluating the impact of the COVID-19 pandemic, the Russia-Ukraine war, and macroeconomic conditions and their effect on the Company’s financial position, results of its operations and/or search for a target company.These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern one year from the date these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Risks and uncertaintiesManagement continues to evaluate the impact of the COVID-19 pandemic on market conditions, along with the ongoing conflict between Russia and Ukraine, and resulting market volatility and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.The ongoing conflict in Ukraine—along with the responses of the governments of the United States, European Union (“EU”)member states, the United Kingdom, and other nations—have the potential to materially adversely affect a potential target business’s operations or assets in—or (direct or indirect) dealings with parties organized or located within—Ukraine, Russia, and Belarus. Due to recent geopolitical developments, the United States, European Union, United Kingdom, and other nations have announced or threatened new sanctions and export restrictions targeting Russian and Belarusian individuals and entities, as well as disputed territories within Ukraine. Russia and its allies may respond with countermeasures, which could further restrict the target business’s operations in or related to the foregoing countries. It is unclear how long existing restrictions (and countermeasures) will remain in place or whether new restrictions (or countermeasures) may be imposed. Existing restrictions have negatively impacted the Russian economy, and there can be no guarantee that existing (or new) restrictions or countermeasures will not materially adversely affect the Russian (or global) economy. Any of the foregoing could have a material adverse impact on a potential target business’s financial condition, results of operations, or prospects. ​​ Note 2 - Significant Accounting Policies Basis of PresentationThe accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the financial statements do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods. 10
Emerging Growth CompanyThe Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statement, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find the Company’s securities less attractive as a result, there may be a less active trading market for its securities and the prices of its securities may be more volatile.In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period. Use of EstimatesThe preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash EquivalentsThe Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2022 and December 31, 2021, the Company had no cash equivalents. Investments held in Trust AccountTrading securities in the Trust Account were invested in U.S. Treasury Securities and marketable securities which are presented on the condensed balance sheets at fair value at the end of each reporting period. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. Gains and losses resulting from the change in fair value of these securities is included in gain on investment held in Trust Account. The estimated fair values of the investments held in the Trust Account are determined using quoted market prices in active markets. Share Based CompensationThe Company accounts for the transfer of Founder Shares to the Company’s Officers and Independent Directors in accordance with ASC Topic 718, “Compensation-Stock Compensation”. The awards have a performance condition that requires the consummation of an initial business combination to fully vest. As the performance condition is not probable, and will likely not become probable until the consummation of an initial business combination, the Company will defer recognition of the compensation costs until the consummation of an initial business combination. Concentration of Credit RiskFinancial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on these accounts. 11
Class A Ordinary Shares Subject to Possible RedemptionThe Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC Topic 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares contain certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2022 and December 31, 2021, 22,500,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, at redemption value, outside of the shareholders’ deficit section of the Company’s balance sheets.The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. Offering Costs associated with the Initial Public OfferingThe Company complies with ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs-SEC Materials”, and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged against the carrying value of Class A ordinary shares or the statements of operations based on the relative value of the Class A ordinary shares and the Public Warrants to the proceeds received from the Units sold upon the completion of the IPO. Fair Value MeasurementsThe fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature. Derivative Financial InstrumentsThe Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. WarrantsThe Company accounts for the Public Warrants and Private Placement Warrants as liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in ASC Topic 480 and ASC Topic 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC Topic 480, meet the definition of a liability pursuant to ASC Topic 480, and whether the warrants meet all of the requirements for equity classification under ASC Topic 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the shareholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as a derivative liability.For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. 12
Income TaxesDeferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s balance sheets. As of September 30, 2022, the Company does not have, and does not expect to have, unrecognized tax benefits over the next twelve months. Net Income (Loss) per Ordinary ShareThe statements of operations include a presentation of income (loss) per Class A redeemable ordinary share and income (loss) per Class B non-redeemable ordinary share following the two-class method of income (loss) per share. In order to determine the net income (loss) attributable to both the Class A redeemable ordinary shares and founder non-redeemable ordinary shares, the Company first considered the total income (loss) allocable to both sets of shares. This is calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the accretion to redemption value of the Class A redeemable ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. Subsequent to calculating the total income (loss) allocable to both sets of shares, the Company split the amount to be allocated using a ratio of 80 % for the Class A redeemable ordinary shares and 20 % for the Class B non-redeemable ordinary shares for the three and nine months ended September 30, 2022, reflective of the respective participation rights. For the three months ended September 30, 2021 and for the period from March 30, 2021 (inception) through September 30, 2021, net loss per ordinary share was calculated by dividing the net loss by the number of Class B non-redeemable ordinary shares, as Class B non-redeemable ordinary shares comprised 100 % of the outstanding shares as of September 30, 2021. 13
| ​ | ​ | ​ | ​ |
| ​ | ​ | Three Months Ended |
| ​ | September 30, 2022 |
| Net income | ​ | $ | 4,829,362 |
| Accretion of temporary equity to redemption value | ​ | ​ | ( 947,639 ) |
| Net income including accretion of temporary equity to redemption value | ​ | $ | 3,881,723 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Three Months Ended |
| ​ | ​ | September 30, 2022 |
| ​ | Class A | Class B |
| Basic and diluted net income per share: | ​ | ​ | ​ | ​ |
| Numerator: | ​ | ​ | ​ |
| Allocation of net income including accretion of temporary equity | ​ | $ | 3,105,379 | ​ | $ | 776,344 |
| Allocation of accretion of temporary equity to redeemable shares | ​ | ​ | 947,639 | ​ | ​ | — |
| Allocation of net income | ​ | $ | 4,053,018 | ​ | $ | 776,344 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Denominator: | ​ | ​ | ​ | ​ | ​ | ​ |
| Weighted average shares outstanding | ​ | ​ | 22,500,000 | ​ | ​ | 5,625,000 |
| Basic and diluted net income per share | ​ | $ | 0.18 | ​ | $ | 0.14 |
| ​ | ​ | ​ | ​ |
| ​ | Nine Months Ended |
| ​ | September 30, 2022 |
| Net income | $ | 6,887,270 |
| Accretion of temporary equity to redemption value | ​ | ​ | ( 1,227,475 ) |
| Net income including accretion of temporary equity to redemption value | $ | 5,659,795 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Nine Months Ended |
| ​ | ​ | September 30, 2022 |
| ​ | Class A | Class B |
| Basic and diluted net income per share: |
| Numerator: | ​ | ​ |
| Allocation of net income including accretion of temporary equity | $ | 4,527,836 | $ | 1,131,959 |
| Allocation of accretion of temporary equity to redeemable shares | ​ | ​ | 1,227,475 | ​ | ​ | — |
| Allocation of net income | $ | 5,755,311 | $ | 1,131,959 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Denominator: | ​ | ​ | ​ | ​ | ​ | ​ |
| Weighted average shares outstanding | ​ | ​ | 22,500,000 | ​ | ​ | 5,625,000 |
| Basic and diluted net income per share | $ | 0.26 | $ | 0.20 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | For the Period From |
| ​ | ​ | ​ | ​ | ​ | March 30, 2021 (Inception) |
| ​ | ​ | Three Months Ended | ​ | Through |
| ​ | September 30, 2021 | September 30, 2021 |
| Net loss | ​ | $ | ( 7,193 ) | ​ | $ | ( 17,001 ) |
| Weighted average Class B ordinary shares outstanding | ​ | ​ | 5,625,000 | ​ | ​ | 5,625,000 |
| Basic and diluted net income per share | ​ | $ | ( 0.00 ) | ​ | $ | ( 0.00 ) |

from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the public shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless.The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Class A ordinary share equals or exceeds $ 10.00 (as adjusted)); (2) they (including the Class A ordinary shares issuable upon exercise of Private Placement Warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial Business Combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. Note 5-Derivative Financial instrumentsWarrantsOn September 30, 2022 and December 31, 2021, 21,000,000 warrants were outstanding ( 11,250,000 Public Warrants and 9,750,000 Private Placement Warrants). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $ 9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $ 9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115 % of the higher of the Market Value and the Newly Issued Price, the $ 18.00 per share redemption trigger price (as described below) will be adjusted (to the nearest cent) to be equal to 180 % of the higher of the Market Value and the Newly Issued Price, and the $ 10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.The warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination and 12 months from the closing of the IPO and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If any such registration statement has not been declared effective by the 60 th business day following the closing of the initial Business Combination, holders of the warrants will have the right, during the period beginning on the 61st business day after the closing of the initial Business Combination and ending upon such registration statement being declared effective by the SEC, and during any other period when the Company fails to have maintained an effective registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, to exercise such warrants on a “cashless basis.” Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they do not satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but will use the Company’s commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In the case of a cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361 Class A ordinary shares per warrant. The “fair market value” as used in the preceding sentence shall mean the volume weighted average price 16
| ● | in whole and not in part; |
| ● | at a price of $ 0.01 per warrant; |
| ● | upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and |
| ● | if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant). |
| ● | in whole and not in part; |
| ● | at $ 0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined above); |
| ● | if, and only if, the Reference Value (as defined above under “—Redemption of Public Warrants when the price per Class A ordinary share equals or exceeds $ 18.00 ”) equals or exceeds $ 10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant); and |
| ● | if the Reference Value is less than $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants. |

Additionally, certain adjustments to the settlement amount of the Private Placement Warrants are based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC Topic 815-40, and thus the Private Placement Warrants are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting. Note 6 - Related Party TransactionsWorking Capital LoansIn order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Company’s Trust Account would be used to repay the Working Capital Loans. Up to $ 1,500,000 of the Working Capital Loans may be convertible into warrants at a price of $ 1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants issued to the Sponsor. The terms of the Working Capital Loans, if any, have not been determined and no written agreements exist with respect to the Working Capital Loans. The Company does not expect to seek loans from parties other than the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers as the Company does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Company’s Trust Account. As of September 30, 2022 and December 31, 2021, the Company had no Working Capital Loans.Administrative Services AgreementThe Company entered into an Administrative Services Agreement pursuant to which it will pay an affiliate of the Sponsor a total of $ 14,000 per month for office space and administrative and support services. The agreement was effective upon the date that securities of the Company were first listed on the New York Stock Exchange, October 22, 2021. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. As of September 30, 2022 and December 31, 2021, the Company accrued $ 158,139 and $ 32,139 , respectively, under the Administrative Services Agreement as due to related party. The $ 42,000 and $ 126,000 incurred for the three and nine months ended September 30, 2022, respectively, have been included in administrative expenses in the statements of operations.Payables to Related PartiesThe due to related party balance in 2021 consisted of administrative fees incurred, but not yet paid, through December 31, 2021 and a legal fee payment made by an affiliate on behalf of the Company. The due to related party balance in 2022 consists solely of administrative fees incurred through September 30, 2022 as the Company repaid the Sponsor for the amounts paid on its behalf. As of September 30, 2022 and December 31, 2021, the Company had a due to related party payable of $ 158,139 and $ 42,776 , respectively, of which $ 0 and $ 10,637 , respectively, were related to amounts owed to the affiliate for legal fees paid on behalf of the Company.Founder SharesOn April 16, 2021, the Sponsor paid $ 25,000 in consideration for 5,750,000 Founder Shares. Up to 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option was exercised.Upon the closing of the IPO, the Anchor Investors received 1,375,000 Founder Shares from the Sponsor.On November 4, 2021, the Sponsor transferred an aggregate of 843,750 Founder Shares to the Company’s officers and independent directors (see Note 8).On December 6, 2021, 125,000 of the Founder Shares were forfeited by the Sponsor as a result of the underwriters’ partial exercise of the over-allotment option and the expiration of the over-allotment option. 18
Promissory NoteOn April 16, 2021, the Sponsor agreed to loan the Company up to $ 300,000 under an unsecured promissory note to be used for a portion of the expenses of the IPO. The Company borrowed $ 212,710 under the $ 300,000 promissory note with its Sponsor. The loan was non-interest bearing, unsecured and was due at the earlier of April 30, 2022 and the closing of the IPO. The loan was fully repaid on October 26, 2021 and the Company is not able to borrow additional amounts under the promissory note since the date of repayment.​ ​ Note 7 - Commitments and ContingenciesRegistration RightsThe holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed in connection with the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statement.Underwriting AgreementThe Company granted the underwriters a 45-day option from the date of the IPO to purchase up to an additional 3,000,000 Units to cover over-allotments, if any.On October 26, 2021, the Company paid a cash underwriting discount of 2.0 % per Unit, or $ 4,000,000 . Additionally, the underwriters will be entitled to a deferred underwriting commission of 3.5 % of the gross proceeds of the IPO totaling $ 7,000,000 upon the completion of the Company’s initial Business Combination.On November 4, 2021, the underwriters partially exercised the over-allotment option and, on November 8, 2021, purchased 2,500,000 Units, generating aggregate gross proceeds of $ 25,000,000 , and the Company incurred $ 500,000 in cash underwriting discounts and $ 875,000 in deferred underwriting commissions. Note 8 – Shareholders’ DeficitPreference shares - The Company is authorized to issue 2,000,000 preference shares, par value of $ 0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.Class A ordinary shares - The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $ 0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 22,500,000 Class A ordinary shares issued and outstanding, including 22,500,000 Class A ordinary shares subject to possible redemption that are classified as temporary equity in the accompanying balance sheets.Class B ordinary shares - The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $ 0.0001 per share. Holders are entitled to one vote for each Class B ordinary share. Upon the closing of the IPO on October 26, 2021, there were 5,750,000 Class B ordinary shares issued and outstanding. Of the 5,750,000 Class B ordinary shares, an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial shareholders would collectively own 20 % of the Company’s issued and outstanding ordinary shares after the IPO. Simultaneously with the closing of the IPO, the Sponsor transferred 1,375,000 Class B ordinary shares to the Anchor Investors. On November 4, 2021, the Sponsor sold an aggregate of 843,750 Class B ordinary shares at a price of $ 0.004 per share and transferred 975,000 Private Placement Warrants to the Company’s officers and independent directors. 19
On December 6, 2021, 125,000 of the Class B ordinary shares were forfeited by the Sponsor as a result of the underwriters’ partial exercise of the over-allotment option and the expiration of the over-allotment option.As of September 30, 2022 and December 31, 2021, there were 5,625,000 Class B ordinary shares issued and outstanding.The sales or transfers of the Class B ordinary shares and Private Placement Warrants to the Company’s officers and independent directors, as described above, is within the scope of ASC Topic 718, “Compensation-Stock Compensation.” Under ASC 718, share-based compensation associated with equity classified awards is measured at fair value upon the grant date. The Private Placement Warrants, which were recorded as a derivative liability, have been settled on the grant date, November 4, 2021. The settlement of the $ 711,750 derivative liability was recorded in accumulated deficit in the accompanying balance sheet as of December 31, 2021.The Class B ordinary shares and Private Placement Warrants were effectively sold or transferred subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to those is recognized only when the performance condition is probable of occurrence under the applicable accounting literature. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Class B ordinary shares granted times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of those shares. As of September 30, 2022, the Company determined that a Business Combination is not probable and therefore, no stock-based compensation expense has been recognized. The unrecognized stock-based compensation expense as of September 30, 2022 was $ 6,719,250 .The Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each ordinary share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided, that, prior to the initial Business Combination, holders of the Class B ordinary shares will have the right to appoint all of the Company’s directors and remove directors for any reason, and holders of the Class A ordinary shares will not be entitled to vote on the appointment of directors during such time.The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one - for-one basis, subject to adjustment for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of the initial Business Combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20 % of the sum of all ordinary shares issued and outstanding upon the completion of the IPO plus all Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination. The term “equity-linked securities” refers to any debt or equity securities that are convertible, exercisable or exchangeable for our Class A ordinary shares issued in a financing transaction in connection with the initial Business Combination, including but not limited to a private placement of equity or debt. 20
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | Quoted Prices in | ​ | Significant Other | ​ | Significant Other |
| ​ | ​ | ​ | ​ | ​ | Active Markets | ​ | Observable Inputs | ​ | Unobservable Inputs |
| ​ | September 30, 2022 | (Level 1) | (Level 2) | (Level 3) |
| Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Marketable Securities held in Trust Account | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| -Cash | ​ | $ | 74 | ​ | $ | 74 | ​ | $ | — | ​ | $ | — |
| -Money Market Funds | ​ | ​ | 113,089,799 | ​ | ​ | 113,089,799 | ​ | — | ​ | — |
| -Treasury Securities | ​ | ​ | 115,399,653 | ​ | ​ | 115,399,653 | ​ | — | ​ | — |
| Total Assets | ​ | $ | 228,489,526 | ​ | $ | 228,489,526 | $ | — | $ | — |
| Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Warrant liabilities - Public Warrants | ​ | $ | 2,362,500 | ​ | $ | 2,362,500 | $ | — | $ | — |
| Warrant liabilities - Private Placement Warrants | ​ | ​ | 1,842,750 | ​ | ​ | — | ​ | 1,842,750 | ​ | ​ | — |
| Total Liabilities | ​ | $ | 4,205,250 | ​ | $ | 2,362,500 | ​ | $ | 1,842,750 | ​ | $ | — |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | Quoted Prices in | ​ | Significant Other | ​ | Significant Other |
| ​ | ​ | ​ | ​ | ​ | Active Markets | ​ | Observable Inputs | ​ | Unobservable Inputs |
| ​ | December 31, 2021 | (Level 1) | (Level 2) | (Level 3) |
| Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Treasury Securities and marketable securities held in Trust Account | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| -Money Market Funds | ​ | $ | 112,628,152 | ​ | $ | 112,628,152 | $ | — | $ | — |
| -Treasury Securities | ​ | ​ | 114,633,899 | ​ | ​ | 114,633,899 | ​ | — | ​ | — |
| Total Assets | ​ | $ | 227,262,051 | ​ | $ | 227,262,051 | $ | — | $ | — |
| Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Warrant liabilities - Public Warrants | ​ | $ | 6,300,000 | ​ | $ | 6,300,000 | $ | — | $ | — |
| Warrant liabilities - Private Placement Warrants | ​ | ​ | 4,748,250 | ​ | ​ | — | ​ | — | ​ | ​ | 4,748,250 |
| Total Liabilities | ​ | $ | 11,048,250 | ​ | $ | 6,300,000 | $ | — | ​ | $ | 4,748,250 |
| ​ | ​ | ​ | ​ |
| ​ | ​ | Warrant |
| ​ | Liability |
| Fair value at March 30, 2021 (inception) | ​ | $ | — |
| Initial classification of Public Warrant and Private Placement Warrant liabilities at October 26, 2021 | ​ | 15,330,000 |
| Transfer of Public Warrant liabilities to Level 1 | ​ | ( 6,300,000 ) |
| Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers (Note 8) | ​ | ( 711,750 ) |
| Change in fair value | ​ | ( 3,570,000 ) |
| Derivative warrant liabilities as of December 31, 2021 | ​ | $ | 4,748,250 |
| Transfer of Private Placement Warrant liability to Level 2 | ​ | ​ | ( 4,387,500 ) |
| Change in fair value | ​ | ( 360,750 ) |
| Derivative warrant liabilities as of March 31, 2022 | ​ | $ | — |
| Change in fair value | ​ | ​ | — |
| Derivative warrant liabilities as of June 30, 2022 | ​ | ​ | — |
| Change in fair value | ​ | ​ | — |
| Derivative warrant liabilities as of September 30, 2022 | ​ | $ | — |

| ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Private Placement Warrants |
| ​ | December 31, 2021 |
| Input | ​ | ​ |
| Exercise price | ​ | $ | 11.50 | ​ |
| Stock price | ​ | $ | 9.81 | ​ |
| Volatility | ​ | 11.0 | % |
| Expected term of the warrants | ​ | 5 | years |
| Risk-free rate | ​ | 1.23 | % |
| Dividend yield | ​ | 0.0 | % |

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this Quarterly Report on Form 10-Q (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Pegasus Digital Mobility Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “sponsor” refer to Pegasus Digital Mobility Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Exchange Act of 1934, as amended (the “Exchange Act”), that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. Actual results and shareholders’ value will be affected by a variety of risks and factors, including, without limitation, international, national and local economic conditions, merger, acquisition and business combination risks, financing risks, geo-political risks, acts of terror or war, and those risk factors described under “Item 1A. Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and “Item 1A. Risk Factors” of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022. Many of the risks and factors that will determine these results and shareholder value are beyond our ability to control or predict. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated on March 30, 2021, as a Cayman Islands exempted company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets (a “business combination”). We have not selected any business combination target, and we have not entered into any definitive agreement to effect a business combination with any target. We intend to effectuate our initial business combination using cash from the net proceeds of our initial public offering (the “initial public offering”) and the private placement of the private placement warrants (as defined below), our shares, debt or a combination of cash, equity and debt.
Pursuant to our amended and restated memorandum and articles of association, if we have not completed our initial business combination within 15 months (extendable at our sponsor’s option up to 21 months) from the closing of our initial public offering, or January 26, 2023 (without extensions), we will (1) cease all operations except for the purpose of winding up, (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as defined below), including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (3) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
As indicated in the financial statements, as of September 30, 2022, we had cash of $501,294. Further, we expect to incur significant costs in the pursuit of our initial business combination. We cannot assure you that our plans to complete our initial business combination will be successful.
24
Results of Operations As of September 30, 2022, we had not commenced any operations. All activity for the period from March 30, 2021 (Inception) through September 30, 2022 relates to our formation and initial public offering, and, since the completion of the initial public offering, our search for a target to consummate a business combination. We will not generate any operating revenues until after the completion of a business combination, at the earliest. We will generate non-operating income in the form of interest income from the proceeds derived from the initial public offering and placed in a U.S.-based trust account (the “Trust Account”) at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.We classify the warrants issued in connection with our initial public offering and private placement as liabilities at their fair value and adjust the warrant instruments to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations.For the three months ended September 30, 2022, we had net income of $4,829,362 which consisted of listing expenses of $21,250, administrative expenses of $51,847, legal and accounting expenses of $72,197, and insurance expense of $178,233, offset by an unrealized gain on fair value changes of warrants of $4,205,250, interest earned on marketable securities held in Trust Account of $381,037, and the unrealized gain on marketable securities (net), dividends and interest on cash held in Trust Account of $566,602. For the three months ended September 30, 2021, the Company had a net loss of $7,193, which consisted solely of formation costs.For the nine months ended September 30, 2022, we had net income of $6,887,270, which consisted of listing expenses of $63,750, administrative expenses of $200,127, legal and accounting expenses of $384,628, and insurance expense of $534,700, offset by an unrealized gain on fair value changes of warrants of $6,843,000, interest earned on marketable securities held in Trust Account of $461,238, and the unrealized gain on marketable securities (net), dividends and interest on cash held in Trust Account of $766,237. For the period from March 30, 2021 (inception) through September 30, 2021, the Company had a net loss of $17,001, which consisted solely of formation costs.Liquidity, Capital Resources and Going ConcernAs of September 30, 2022, we had $501,294 in cash held outside of the Trust Account and working capital of $383,424. Following our initial public offering and the sale of warrants in a private placement (the “private placement warrants”) to the Sponsor, a total of $227,250,000 was placed in the Trust Account.For the nine months ended September 30, 2022, net cash used in operating activities was $530,103. Net income of $6,887,270 was adjusted by interest earned on Treasury Securities held in Trust Account of $461,238, unrealized gains on marketable securities (net), dividends and interest on cash held in Trust Account of $766,237, $6,843,000 unrealized gain on fair value change in warrants, and $653,102 changes in operating assets and liabilities.As of September 30, 2022, we had marketable securities, and cash held in the Trust Account of $228,489,526 (including $1,239,526 of interest and unrealized gains on marketable securities (net) from October 21, 2021 through September 30, 2022) consisting of securities held in Treasury Securities and a money market fund that invests in U.S. Treasury securities with a maturity of 185 days or less.As of September 30, 2022, we had cash of $501,294 held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.We may need to raise additional funds in order to meet the expenditures required for operating our business prior to our initial business combination. We expect to incur significant costs related to identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination. These conditions raise substantial doubt about our ability to continue as a going concern for a period of time within one year from the date that the financial statements accompanying this Quarterly Report are issued.25
In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants. As of September 30, 2022, we did not have any outstanding working capital loans.Critical Accounting EstimatesThe preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any additional critical accounting estimates that were not disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021 or Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022.Recent Accounting PronouncementsSee Note 2 to the financial statements required by Item 1 of this Quarterly Report.JOBS ActThe Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board (United States) regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the date of the first sale of securities in our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this Item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-
26
15(e) and 15d-15(e) under the Exchange Act, as of the end of the fiscal quarter ended September 30, 2022. Based on this evaluation, our principal executive officer and principal financial officer have concluded that, as of the evaluation date, our disclosure controls and procedures were effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.Changes in Internal Control over Financial ReportingThere was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2022 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.​PART II-OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 1A. Risk Factors.
There have been no material changes from the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Use of Proceeds
On October 26, 2021, we consummated our initial public offering of 20,000,000 units (“units”), and, on November 8, 2021, we consummated the sale of 2,500,000 units as a result of the underwriters’ partial exercise of their over-allotment option. Each unit consists of one Class A ordinary share, par value $0.0001 per share (the “Class A ordinary shares”), and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one of our Class A ordinary shares at a price of $11.50 per share, subject to certain adjustments. The units were sold at a price of $10.00 per unit, generating aggregate gross proceeds to the Company of $225,000,000. Barclays Capital Inc. served as the sole book-running manager for the initial public offering, and EarlyBirdCapital, Inc., Ladenburg Thalmann & Co. Inc. and Northland Securities, Inc. served as co-managers for the initial public offering. The securities sold in our initial public offering were registered under the Securities Act on a registration statement on Form S-1 (File No. 333-259860). The registration statement became effective on October 21, 2021.
Following our initial public offering and the sale of the private placement warrants, a total of $227,250,000 of the net proceeds from the sale of the units and private placement warrants was deposited in the Trust Account. Transaction costs related to the consummation of the initial public offering amounted to $13,124,654, consisting of $4,500,000 of underwriting discounts, $7,875,000 of deferred underwriting commissions, and $749,654 of other offering costs. In addition, as of September 30, 2022, $501,294 of cash was held outside of the Trust Account and was available for working capital purposes.
For a description of the use of the net proceeds from our initial public offering, see Part I, Item 2 of this Quarterly Report.
27
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
​
28
Item 6. Exhibits.
The following exhibits are filed as part of this report or incorporated herein by reference.
| ExhibitNumber | Description |
| 3.1 | ​ | Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on October 26, 2021). |
| 4.1 | ​ | Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1/A (File No. 333-259860) filed on October 8, 2021). |
| 4.2 | ​ | Specimen Class A Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1/A (File No. 333-259860) filed on October 8, 2021). |
| 4.3 | ​ | Specimen Warrant Certificate (included in Exhibit 4.4) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 26, 2021). |
| 4.4 | ​ | Warrant Agreement, dated October 21, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on October 26, 2021). |
| 31.1* | Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d) to 14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d) to 14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1** | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2** | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS* | XBRL Instance Document |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.SCH* | XBRL Taxonomy Extension Schema Document |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104* | ​ | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101) |

*Filed herewith.
**These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
​
29
| ​ | ​ | ​ |
| Dated: November 14, 2022 | Pegasus Digital Mobility Acquisition Corp. |
| ​ | ​ | ​ |
| ​ | By: | /s/ Dr. Sir Ralf Speth |
| ​ | Name: | Dr. Sir Ralf Speth |
| ​ | Title: | Chief Executive Officer and Chairman of the Board of Directors |
| ​ | ​ | ​ |
| Dated: November 14, 2022 | By: | /s/ F. Jeremey Mistry |
| ​ | Name: | F. Jeremey Mistry |
| ​ | Title: | Chief Financial Officer and Secretary |
| ​ | ​ | ​ |


Question: What is the difference in days between the Filing date of the Specimen Unit Certificate and the Warrant Agreement?

Solution:
def solution():
     # Define variables name and value

    specimen_unit_filing_date = 'October 8, 2021'  # Filing date of Specimen Unit Certificate

    warrant_agreement_filing_date = 'October 26, 2021'  # Filing date of Warrant Agreement

    # Convert the string to datetime object
    from datetime import datetime
    specimen_unit_filing_date = datetime.strptime(specimen_unit_filing_date, '%B %d, %Y')
    warrant_agreement_filing_date = datetime.strptime(warrant_agreement_filing_date, '%B %d, %Y')

    # Do math calculation to get the answer
    answer = (warrant_agreement_filing_date - specimen_unit_filing_date).days
    return answer


Answer: 18